Comparable stake leader
EW HEALTHCARE PARTNERS FUND 2, L.P.
SEC ownership of TELA Bio, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001561921.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
7/50
Latest evidence
15 Oct 2026
- Public ticker
- TELA on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
EW HEALTHCARE PARTNERS FUND 2, L.P.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
7 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
EW HEALTHCARE PARTNERS FUND 2, L.P.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
15 Oct 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001561921
- Issuer location
- Malvern, PA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of TELA Bio, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EW HEALTHCARE PARTNERS FU...
Disclosed value leader
Opaleye Management Inc.
Comparable rows
7/50
Latest evidence
15 Oct 2026
3/4/5
13D/G
13F
Lead comparable stake: 17%
43 rows are not safely comparable across share classes.
13D/G row: EW HEALTHCARE PARTNERS FUND 2, L.P.
Showing 1-8 of 50 holder rows.
Quick read
EW HEALTHCARE PARTNERS FUND 2, L.P. leads the comparable SEC ownership view at 17%.
7 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EW HEALTHCARE PARTNERS FUND 2, L.P.'s linked filing trail.
Comparable ownership
Top 5
EW HEALTHCARE PARTNERS FUND 2, L.P.
17%
Nantahala Capital Management, LLC
13%
NORTH RUN CAPITAL, LP
9.3%
Stonepine Capital Management, LLC
6%
Laurence W. Lytton
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EW HEALTHCARE PARTNERS FUND 2, L.P. |
3/4/5
13D/G
Other*, 10%+ Owner · EW Healthcare Partners Fund 2-GP, L.P.
|
17%
Reported 13D/G
· 09 Jun 2026
|
$8,563,326
7,714,709 shares
|
+$4,000,440 | 17 Nov 2025 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
13%
Reported 13D/G
· 30 Jun 2026
|
$4,751,173
5,794,114 shares
|
+$559,671 | 30 Jun 2026 |
| NORTH RUN CAPITAL, LP |
13D/G
|
9.3%
Reported 13D/G
· 31 Mar 2025
|
$3,608,839
3,682,489 shares
|
+$1,666,000 | 31 Mar 2025 |
| Stonepine Capital Management, LLC |
13D/G
13F
Company
|
6%
Reported 13D/G
· 31 Dec 2024
|
$2,211,913
2,353,099 shares
|
$0 | 31 Dec 2024 |
| Laurence W. Lytton |
13D/G
Lytton, Laurence W.
|
5.5%
Reported 13D/G
· 31 Mar 2026
|
$1,465,405
2,442,341 shares
|
-$253,778 | 31 Mar 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13D/G
13F
Company
|
4.8%
Reported 13D/G
· 30 Jun 2026
|
$1,752,505
2,137,201 shares
|
-$761,327 | 30 Jun 2026 |
| Orin Hirschman |
13D/G
|
3.6%
Reported 13D/G
· 31 Mar 2025
|
$1,331,344
1,416,323 shares
|
-$1,171,674 | 31 Mar 2025 |
| Opaleye Management Inc. |
3/4/5
Former 10% Owner.
|
—
denominator unverified
|
$11,710,150
2,072,813 shares
|
— | 20 Apr 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$4,186,456.
Buys
$4,186,456
Insiders: 3
Sells
$0
Insiders: 0
Net
+$4,186,456
Shares: +3,781,500
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 3,781,500
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 177,500 | 0 | $186,016 | $0 | +$186,016 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 3,604,000 | 0 | $4,000,440 | $0 | +$4,000,440 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 26 reporting-owner rows connected to TELA Bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
26
Largest Forms 3/4/5 holder
Opaleye Management Inc.
Net 12M change
+$4,186,456
Latest report
15 Oct 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Opaleye Management Inc. | Former 10% Owner. | $11,710,150 | Mixed | 20 Apr 2023 | ||
| ORBIMED ADVISORS LLC | 10%+ Owner | $10,928,879 | Filing P/S | 28 Jun 2024 | ||
| EW HEALTHCARE PARTNERS FUND 2, L.P. | Other*, 10%+ Owner | $8,563,326 | +$4,000,440 | +88% | Filing P/S | 17 Nov 2025 |
| Antony Koblish | Chief Executive Officer, Director | $460,292 | Mixed | 20 Feb 2026 | ||
| Heather C. Getz | Chief Executive Officer, Director | $354,059 | +$18,778 | +5.6% | Filing P/S | 17 Aug 2026 |
| Peter C. Murphy | Chief Commercial Officer | $272,891 | Mixed | 31 Mar 2024 | ||
| Joseph H. Capper | Director | $247,538 | +$167,238 | +208% | Median | 15 Oct 2026 |
| Jeffrey Blizard | President | $201,022 | Mixed | 20 Feb 2026 | ||
| Roberto Cuca | COO and CFO | $197,150 | Mixed | 20 Feb 2026 | ||
| Ellis Skott Greenhalgh | Chief Technology Officer | $157,200 | Mixed | 24 Feb 2022 | ||
| Paul Talmo | Chief Technology Officer | $132,851 | Mixed | 20 Feb 2026 | ||
| Gregory A. Firestone | Chief Business Officer | $106,709 | Mixed | 20 Feb 2026 | ||
| William J. Plovanic | Director | $75,167 | Median | 15 Oct 2026 | ||
| Howard N. Langstein | Chief Medical Officer | $71,347 | Mixed | 01 Mar 2026 | ||
| Megan Smeykal | Chief Accounting Officer | $51,224 | Mixed | 18 Feb 2026 | ||
| John Nosenzo | Director | $35,422 | Mixed | 01 Jun 2023 | ||
| Vincent J. Burgess | Director | $22,863 | Mixed | 28 May 2025 | ||
| Kurt Azarbarzin | Director | $18,100 | Mixed | 28 May 2025 | ||
| Federica F. O'Brien | Director | $18,100 | Mixed | 28 May 2025 | ||
| Douglas G. Evans | Director | $18,100 | Mixed | 28 May 2025 |
Recent insider transactions for TELA Bio, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Joseph H. Capper | TELA | Common Stock | Award | 11% | 19,801 | 199,628 | 15 Oct 2026 | Direct | ||
| William J. Plovanic | TELA | Common Stock | Award | 36.1% | 16,089 | 60,619 | 15 Oct 2026 | Direct | ||
| Joseph H. Capper | TELA | Common Stock | Purchase | 16.2% | $30,530 | $1.22 | 25,000 | 179,827 | 17 Sep 2026 | Direct |
| Joseph H. Capper | TELA | Common Stock | Purchase | 47.7% | $58,265 | $1.17 | 50,000 | 154,827 | 16 Sep 2026 | Direct |
| Joseph H. Capper | TELA | Common Stock | Purchase | 91.2% | $52,940 | $1.06 | 50,000 | 104,827 | 15 Sep 2026 | Direct |
| Joseph H. Capper | TELA | Common Stock | Purchase | 83.8% | $25,502 | $1.02 | 25,000 | 54,827 | 14 Sep 2026 | Direct |
| Heather C. Getz | TELA | Common Stock | Purchase | 2.4% | $8,311 | $0.6649 | 12,500 | 532,500 | 17 Aug 2026 | Direct |
| Heather C. Getz | TELA | Common Stock | Purchase | 2.97% | $10,467 | $0.6978 | 15,000 | 520,000 | 14 Aug 2026 | Direct |
| Heather C. Getz | TELA | Common Stock | Award | 10000% | 500,000 | 505,000 | 03 Aug 2026 | Direct | ||
| Heather C. Getz | TELA | Stock Option (Right to Buy) | Award | 2,370,000 | 1,365,000 | 03 Aug 2026 | Direct | |||
| William J. Plovanic | TELA | Common Stock | Award | 88.7% | 20,930 | 44,530 | 15 Jul 2026 | Direct | ||
| Joseph H. Capper | TELA | Common Stock | Award | 26.4% | 6,227 | 29,827 | 15 Jul 2026 | Direct | ||
| Betty Jo Rocchio | TELA | Common Stock | Award | 97.9% | 11,675 | 23,600 | 09 Jun 2026 | Direct | ||
| Betty Jo Rocchio | TELA | Stock Option (Right to Buy) | Award | 17,335 | 17,335 | 09 Jun 2026 | Direct | |||
| Joseph H. Capper | TELA | Common Stock | Award | 23,600 | 23,600 | 09 Jun 2026 | Direct | |||
| Joseph H. Capper | TELA | Stock Option (Right to Buy) | Award | 34,885 | 17,550 | 09 Jun 2026 | Direct | |||
| William J. Plovanic | TELA | Common Stock | Award | 97.9% | 11,675 | 23,600 | 09 Jun 2026 | Direct | ||
| William J. Plovanic | TELA | Stock Option (Right to Buy) | Award | 17,335 | 17,335 | 09 Jun 2026 | Direct | |||
| Guido J. Neels | TELA | Common Stock | Award | 23,600 | 23,600 | 09 Jun 2026 | Direct | |||
| Guido J. Neels | TELA | Stock Option (Right to Buy) | Award | 34,885 | 17,550 | 09 Jun 2026 | Direct | |||
| Paul Thomas | TELA | Common Stock | Award | 23,600 | 23,600 | 09 Jun 2026 | Direct | |||
| Paul Thomas | TELA | Stock Option (Right to Buy) | Award | 34,885 | 17,550 | 09 Jun 2026 | Direct | |||
| Guy P. Nohra | TELA | Common Stock | Award | 23,600 | 23,600 | 09 Jun 2026 | Direct | |||
| Guy P. Nohra | TELA | Stock Option (Right to Buy) | Award | 34,885 | 17,550 | 09 Jun 2026 | Direct | |||
| Antony Koblish | TELA | Common Stock | Tax liability | -0.66% | -3,900 | 586,210 | 24 Feb 2026 | Direct | ||
| Antony Koblish | TELA | Common Stock | Tax liability | -1.54% | -11,631 | 741,985 | 23 Feb 2026 | Direct | ||
| Gregory A. Firestone | TELA | Common Stock | Tax liability | -0.96% | -1,352 | 139,307 | 23 Feb 2026 | Direct | ||
| Paul Talmo | TELA | Common Stock | Tax liability | -2.29% | -4,061 | 173,436 | 23 Feb 2026 | Direct | ||
| Roberto Cuca | TELA | Common Stock | Tax liability | -1.99% | -5,234 | 257,377 | 23 Feb 2026 | Direct | ||
| Megan Smeykal | TELA | Common Stock | Tax liability | -0.63% | -423 | 66,873 | 23 Feb 2026 | Direct | ||
| Antony Koblish | TELA | Common Stock | Tax liability | -1.63% | -12,494 | 753,616 | 21 Feb 2026 | Direct | ||
| Gregory A. Firestone | TELA | Common Stock | Tax liability | -2.89% | -4,189 | 140,659 | 21 Feb 2026 | Direct | ||
| Paul Talmo | TELA | Common Stock | Tax liability | -1.87% | -3,385 | 177,497 | 21 Feb 2026 | Direct | ||
| Roberto Cuca | TELA | Common Stock | Tax liability | -1.79% | -4,780 | 262,611 | 21 Feb 2026 | Direct | ||
| Megan Smeykal | TELA | Common Stock | Tax liability | -2.31% | -1,590 | 67,296 | 21 Feb 2026 | Direct | ||
| Antony Koblish | TELA | Common Stock | Award | 29.8% | 176,000 | 766,110 | 20 Feb 2026 | Direct | ||
| Antony Koblish | TELA | Stock Option (Right to Buy) | Award | 261,000 | 261,000 | 20 Feb 2026 | Direct | |||
| Gregory A. Firestone | TELA | Common Stock | Award | 34.3% | 37,000 | 144,848 | 20 Feb 2026 | Direct | ||
| Gregory A. Firestone | TELA | Stock Option (Right to Buy) | Award | 55,000 | 55,000 | 20 Feb 2026 | Direct | |||
| Paul Talmo | TELA | Common Stock | Award | 46% | 57,000 | 180,882 | 20 Feb 2026 | Direct | ||
| Paul Talmo | TELA | Stock Option (Right to Buy) | Award | 85,000 | 85,000 | 20 Feb 2026 | Direct | |||
| Roberto Cuca | TELA | Common Stock | Award | 27.1% | 57,000 | 267,391 | 20 Feb 2026 | Direct | ||
| Roberto Cuca | TELA | Stock Option (Right to Buy) | Award | 85,000 | 85,000 | 20 Feb 2026 | Direct | |||
| Jeffrey Blizard | TELA | Common Stock | Award | 72.2% | 86,000 | 205,125 | 20 Feb 2026 | Direct | ||
| Jeffrey Blizard | TELA | Stock Option (Right to Buy) | Award | 127,000 | 127,000 | 20 Feb 2026 | Direct | |||
| Megan Smeykal | TELA | Common Stock | Tax liability | -1.14% | -795 | 68,886 | 19 Feb 2026 | Direct | ||
| Megan Smeykal | TELA | Common Stock | Award | 89.2% | 32,850 | 69,681 | 18 Feb 2026 | Direct | ||
| Ew Healthcare Partners Fund 2, L.P. | TELA | Common Stock, par value $0.001 per share | Purchase | 87.7% | $4,000,440 | $1.11 | 3,604,000 | 7,714,709 | 17 Nov 2025 | Direct |
| William J. Plovanic | TELA | Common Stock | Award | 11,925 | 11,925 | 31 Oct 2025 | Direct | |||
| William J. Plovanic | TELA | Stock Option (Right to Buy) | Award | 17,550 | 17,550 | 31 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.